Indra Neil Guha
About
Indra Neil Guha is a scholar working on Epidemiology, Hepatology and Surgery.
According to data from OpenAlex, Indra Neil Guha has authored 112 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Epidemiology, 79 papers in Hepatology and 21 papers in Surgery. Recurrent topics in Indra Neil Guha's work include Liver Disease Diagnosis and Treatment (92 papers), Liver Disease and Transplantation (55 papers) and Hepatitis C virus research (19 papers). Indra Neil Guha is often cited by papers focused on Liver Disease Diagnosis and Treatment (92 papers), Liver Disease and Transplantation (55 papers) and Hepatitis C virus research (19 papers). Indra Neil Guha collaborates with scholars based in United Kingdom, United States and France. Indra Neil Guha's co-authors include Guruprasad P. Aithal, William Rosenberg, Julie Parkes, Paul Roderick, Stephen Ryder, Scott Harris, Philip N. Newsome, Quentin M. Anstee, Emmanuel Tsochatzis and Pierre Bédossa and has published in prestigious journals such as Nature Medicine, Gastroenterology and Hepatology.
In The Last Decade
Indra Neil Guha
111 papers receiving 4.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Indra Neil Guha United Kingdom | 34 | 3.8k | 2.9k | 851 | 809 | 449 | 112 | 4.6k | ||
| Curtis K. Argo United States | 34 | 3.3k 0.9× | 2.4k 0.8× | 1.2k 1.4× | 1.1k 1.3× | 452 1.0× | 81 | 4.4k | ||
| Giada Sebastiani Canada | 39 | 5.4k 1.4× | 4.0k 1.4× | 759 0.9× | 1.0k 1.3× | 431 1.0× | 164 | 6.4k | ||
| Wah‐Kheong Chan Malaysia | 30 | 2.8k 0.7× | 1.4k 0.5× | 768 0.9× | 1.1k 1.3× | 409 0.9× | 112 | 3.7k | ||
| M. Munteanu France | 40 | 4.9k 1.3× | 3.8k 1.3× | 482 0.6× | 788 1.0× | 475 1.1× | 119 | 5.4k | ||
| Françoise Imbert‐Bismut France | 35 | 5.1k 1.3× | 4.2k 1.5× | 447 0.5× | 568 0.7× | 352 0.8× | 86 | 5.8k | ||
| Daniela Cabibi Italy | 35 | 2.6k 0.7× | 1.5k 0.5× | 677 0.8× | 804 1.0× | 731 1.6× | 160 | 4.2k | ||
| Kento Imajo Japan | 40 | 4.2k 1.1× | 2.3k 0.8× | 821 1.0× | 1.5k 1.8× | 374 0.8× | 142 | 5.1k | ||
| Phunchai Charatcharoenwitthaya Thailand | 26 | 4.9k 1.3× | 2.9k 1.0× | 1.3k 1.5× | 1.9k 2.3× | 695 1.5× | 123 | 5.7k | ||
| Michelle Lai United States | 23 | 2.1k 0.5× | 1.5k 0.5× | 712 0.8× | 631 0.8× | 166 0.4× | 54 | 2.8k | ||
| Jill C. Keach United States | 23 | 4.9k 1.3× | 3.7k 1.3× | 1.9k 2.3× | 1.4k 1.7× | 654 1.5× | 33 | 6.1k |
Countries citing papers authored by Indra Neil Guha
Since
Specialization
Citations
This map shows the geographic impact of Indra Neil Guha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indra Neil Guha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indra Neil Guha more than expected).
Fields of papers citing papers by Indra Neil Guha
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Indra Neil Guha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indra Neil Guha. The network helps show where Indra Neil Guha may publish in the future.
Co-authorship network of co-authors of Indra Neil Guha
This figure shows the co-authorship network connecting the top 25 collaborators of Indra Neil Guha. A scholar is included among the top collaborators of Indra Neil Guha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indra Neil Guha. Indra Neil Guha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Llewellyn, Jessica, James Pritchett, Leo Zeef, et al.. (2023). Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease. Cells. 12(12). 1582–1582.
2.
MacDonald, Douglas, Paul Richardson, Stephen Ryder, et al.. (2023). Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK. Liver International. 43(4). 917–927.
3.
Nielsen, Mette Juul, Grace Dolman, Rebecca Harris, et al.. (2023). PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease. JHEP Reports. 5(6). 100743–100743.
4.
McLachlan, Stela, Jonathan Fallowfield, Peter Hayes, et al.. (2021). Addition of hyaluronic acid to the FIB‐4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Obesity Science & Practice. 7(5). 497–508.
5.
Innes, Hamish, Peter Jepsen, Scott McDonald, et al.. (2021). Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection. JHEP Reports. 3(6). 100384–100384.
6.
McLachlan, Stela, Jonathan Fallowfield, Patrick K. A. Kearns, et al.. (2020). Non‐invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study. Liver International. 40(9). 2252–2262.
7.
Chalmers, J. M., et al.. (2020). Detecting chronic liver disease: are liver function tests the solution?. British Journal of Hospital Medicine. 81(2). 1–8.
8.
Trivedi, Palak, Andrew J. Muir, Cynthia Levy, et al.. (2020). Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology. 19(6). 1248–1257.
9.
Eddowes, Peter, M. Sasso, Michael Allison, et al.. (2019). Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 156(6). 1717–1730.
10.
Athwal, Varinder, James Pritchett, Katherine J. Martin, et al.. (2018). SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis. Scientific Reports. 8(1). 17905–17905.
11.
Bradley, Christopher R., Robert A. Scott, Eleanor Cox, et al.. (2018). Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients. European Radiology. 29(6). 3100–3107.
12.
Ginès, Pere, Isabel Graupera, Frank Lammert, et al.. (2016). Screening for liver fibrosis in the general population: a call for action. The Lancet. Gastroenterology & hepatology. 1(3). 256–260.
13.
King, Andrew, Darren Barton, Nwe Ni Than, et al.. (2015). REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial. BMJ Open. 5(3). e007700–e007700.
14.
Bowlus, Christopher L., Kalpesh Patel, Indra Neil Guha, et al.. (2015). Validation of serum fibrosis marker panels in patients with primary sclerosing cholangitis (PSC) in a randomized trial of simtuzumab. Hepatology. 62.
15.
Morling, Joanne R, Jonathan Fallowfield, Indra Neil Guha, et al.. (2015). Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. QJM. 109(4). 249–256.
16.
Tanajewski, Łukasz, Rebecca Harris, D. J. Harman, et al.. (2015). Earlier Detection And Treatment of Non-Alcoholic Fatty Liver Disease: An Economic Evaluation to Appraise An Innovative Diagnostic Pathway to Detect And Intervene Where There Are Known Risk Factors. Value in Health. 18(7). A627–A627.
17.
Hoad, Caroline L., Naaventhan Palaniyappan, P Kaye, et al.. (2013). 703 QUANTITATIVE MAGNETIC RESONANCE IMAGING (MRI) IN THE EVALUATION OF THE DEGREE OF STEATOSIS, IRON ACCUMULATION AND FIBROSIS IN CHRONIC LIVER DISEASE (MRker STUDY). Journal of Hepatology. 58. S285–S286.
18.
Cox, Eleanor, Mikin Patel, Andrew P. Jackson, et al.. (2012). PTU-029 A novel MRI protocol to examine haemodynamic compartments in compensated liver cirrhosis: Abstract PTU-029 Figure 1. Gut. 61(Suppl 2). A195.2–A196.
19.
Dolman, Grace, et al.. (2012). PMO-150 Second harmonic generation microscopy of collagen and evaluation of liver fibrosis in chronic hepatitis C (CHC) infection: Abstract PMO-150 Figure 1. Gut. 61(Suppl 2). A134.1–A134.
20.
Guha, Indra Neil, Robert P. Myers, Keyur Patel, & Jayant A. Talwalkar. (2011). Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve?. Hepatology. 54(4). 1454–1462.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Curtis K. Argo Breakdown of academic impact, for papers by Giada Sebastiani Breakdown of academic impact, for papers by Wah‐Kheong Chan Breakdown of academic impact, for papers by M. Munteanu Breakdown of academic impact, for papers by Françoise Imbert‐Bismut Breakdown of academic impact, for papers by Daniela Cabibi Breakdown of academic impact, for papers by Kento Imajo Breakdown of academic impact, for papers by Phunchai Charatcharoenwitthaya Breakdown of academic impact, for papers by Michelle Lai Breakdown of academic impact, for papers by Jill C. Keach